据公司董事、副总经理、药物研究院院长宋更申介绍，悦康药业目前共有两大策略，新药策略包括创新药要聚焦心脑血管、抗肿瘤、传染病等核心适应症，聚焦核酸、多肽、细胞与基因治疗、小分子化药和特色中药等技术路线，同时依靠核心技术平台发展改良型新药；高端仿制药策略则是通过原料药-辅料-制剂一体化布局，研发具有一定技术壁垒的仿制药。

AI-generated image of cancer being attacked by an mRNA vaccine. In the midst of the COVID-19 pandemic, scientists raced to develop vaccines in record time. The first reliable vaccines, using ...

The mRNA Vaccines Market grew from USD 9.32 billion in 2024 to USD 10.40 billion in 2025. It is expected to continue growing at a CAGR of 11.86%, reaching USD 18.28 billion by 2030.

Get Instant Summarized Text (Gist) The NIH has reportedly advised scientists to omit mRNA vaccine references from grant applications, suggesting a potential shift away from this research area ...

Officials at the National Institutes of Health (NIH) have reportedly told scientists to scrub all references to mRNA vaccine technology from grant applications, sparking fears that the agency ...

悦康药业在2024年进一步完善了其技术平台建设，特别是在小核酸药物和mRNA疫苗领域，公司已搭建了从靶点发现、序列设计、工艺开发到规模化生产的全链条研发平台。公司自主研发的GalNAc肝靶向递送技术、Cap1型加帽类似物以及自复制mRNA疫苗技术等多项核心技术 ...

Federal support for mRNA vaccine research appears in jeopardy after KFF Health News reported Sunday that officials at the National Institutes of Health have directed scientists to remove all ...

Scientists at Shinshu University School of Medicine have developed a synthetic mRNA that, when injected, revitalizes the immune system to recognize and attack metastasizing cancer cells.

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their grant applications, two researchers said, in a move that signaled the ...

Officials at the National Institutes of Health (NIH) have reportedly told scientists to scrub all references to mRNA vaccine technology from grant applications, sparking fears that the agency could ...

Moderna's covid-19 vaccine was created using mRNA technology. Scientists are now worried the Trump administration is going to curtail mRNA research. (Eric Lee for The Washington Post via Getty Images) ...